Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to July 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $1.2B |
| Sales growthchange from the year before | +22.6% |
| Gross marginshare of sales left after the direct cost of what it sells | 62.5% |
| Operating marginshare of sales left after running the business | 3.4% |
| Net marginshare of sales kept as profit | 5.8% |
| Free-cash-flow marginspare cash generated per $100 of sales | 24.5% |
| Return on invested capitalprofit made on each $100 put into the business | 2.1% |
| Return on equityprofit vs. shareholders' accounting value | 4.6% |
| Interest coverhow many times profit covers interest payments | 3.1x |
| Change in share countnegative = the company is buying back its shares | +4.4% |
1 insider sold $535K (all under pre-arranged plans) on the open market.
| Rosenbaum Michael GeorgeChief Executive Officer · Director | Sold (plan)Aug 3 | 1,200 shat $155.92 · $187K |
| Rosenbaum Michael GeorgeChief Executive Officer · Director | Sold (plan)Jul 27 | 1,200 shat $142.31 · $171K |
| Rosenbaum Michael GeorgeChief Executive Officer · Director | Sold (plan)Jul 20 | 1,200 shat $147.42 · $177K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy